Cargando…
Identification of a Novel Bcl-2 Inhibitor by Ligand-Based Screening and Investigation of Its Anti-cancer Effect on Human Breast Cancer Cells
Bcl-2 family protein is an important factor in regulating apoptosis and is associated with cancer. The anti-apoptotic proteins of Bcl-2 family, such as Bcl-2, are overexpression in numerous tumors, and contribute to cancer formation, development, and therapy resistance. Therefore, Bcl-2 is a promisi...
Autores principales: | Wen, Mei, Deng, Zhen-ke, Jiang, Shi-long, Guan, Yi-di, Wu, Hai-zhou, Wang, Xin-luan, Xiao, Song-shu, Zhang, Yi, Yang, Jin-ming, Cao, Dong-sheng, Cheng, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478794/ https://www.ncbi.nlm.nih.gov/pubmed/31057406 http://dx.doi.org/10.3389/fphar.2019.00391 |
Ejemplares similares
-
Mechanisms of action of the BCL-2 inhibitor venetoclax in multiple myeloma: a literature review
por: Cao, Qiang, et al.
Publicado: (2023) -
Tilianin Reduces Apoptosis via the ERK/EGR1/BCL2L1 Pathway in Ischemia/Reperfusion-Induced Acute Kidney Injury Mice
por: Liu, Zengying, et al.
Publicado: (2022) -
Small-molecule BCL6 inhibitor protects chronic cardiac transplant rejection and inhibits T follicular helper cell expansion and humoral response
por: Xia, Yuxuan, et al.
Publicado: (2023) -
Inhibition of BCL9 Modulates the Cellular Landscape of Tumor-Associated Macrophages in the Tumor Immune Microenvironment of Colorectal Cancer
por: Wei, Zhuang, et al.
Publicado: (2021) -
An Integrated Deep Learning and Molecular Dynamics Simulation-Based Screening Pipeline Identifies Inhibitors of a New Cancer Drug Target TIPE2
por: Zhang, Haiping, et al.
Publicado: (2021)